Francois Huet

Francois Huet is a highly experienced Principal Scientist and Associate Director at Biogen, with expertise in preclinical safety and pharmacology spanning over two decades. At Novartis, Francois contributed as a Preclinical Safety Study Monitor and Senior Investigator, focusing on ophthalmology and oncology programs while actively participating in clinical strategy decisions. Previously at Syntonix, Francois led in vivo pharmacology efforts for hemophilia treatments, and at EnVivo Pharmaceuticals, directed research on small molecule compounds, which successfully identified a clinical drug candidate. Francois began a career in academia as an instructor at Massachusetts General Hospital. Francois holds a post-doctoral degree in Genetics and Molecular Biology from Harvard University and a Ph.D. in Molecular and Cellular Biology from Université Louis Pasteur.